AZD8529
- Generic Name
- AZD8529
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H24F3N5O3
- CAS Number
- 1092453-15-0
- Unique Ingredient Identifier
- 6H81G454I7
- Background
AZD8529 is under investigation in clinical trial NCT00921804 (Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients).
- Associated Conditions
- -
- Associated Therapies
- -
The Study of AZD8529 for Smoking Cessation in Female Smokers
- First Posted Date
- 2015-03-27
- Last Posted Date
- 2017-11-29
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 214
- Registration Number
- NCT02401022
- Locations
- ๐บ๐ธ
University of Cincinnati, Cincinnati, Ohio, United States
๐บ๐ธPharmacology Research Institute, Newport Beach, California, United States
๐บ๐ธCenters for the Studies of Addiction, Philadelphia, Pennsylvania, United States
The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics
- First Posted Date
- 2009-09-30
- Last Posted Date
- 2011-11-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 59
- Registration Number
- NCT00986531
- Locations
- ๐บ๐ธ
Research Site, Philadelphia, Pennsylvania, United States
The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2009-09-29
- Last Posted Date
- 2011-05-04
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 20
- Registration Number
- NCT00985933
- Locations
- ๐บ๐ธ
Research Site, New Haven, Connecticut, United States
Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients
- Conditions
- Interventions
- First Posted Date
- 2009-06-16
- Last Posted Date
- 2010-06-30
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 296
- Registration Number
- NCT00921804
- Locations
- ๐บ๐ธ
Research Site, Rockville, Maryland, United States
AZD8529 Single Ascending Dose Study in Healthy Japanese Subjects
- First Posted Date
- 2009-04-23
- Last Posted Date
- 2009-08-19
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 48
- Registration Number
- NCT00886756
- Locations
- ๐ฌ๐ง
Research Site, London, United Kingdom
AZD8529 Multiple Ascending Dose Study in Healthy Subjects
- First Posted Date
- 2008-10-03
- Last Posted Date
- 2009-06-26
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 47
- Registration Number
- NCT00765492
AZD8529 Single Ascending Dose Study
- First Posted Date
- 2008-09-19
- Last Posted Date
- 2009-03-26
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 58
- Registration Number
- NCT00755378
- Locations
- ๐บ๐ธ
Research Site, Philadelphia, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.